Compare GTN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTN | EOLS |
|---|---|---|
| Founded | 1897 | 2012 |
| Country | United States | United States |
| Employees | 9582 | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.5M | 407.0M |
| IPO Year | N/A | 2018 |
| Metric | GTN | EOLS |
|---|---|---|
| Price | $4.09 | $6.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $8.50 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 1.4M | 945.8K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.79% | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $297,176,000.00 |
| Revenue This Year | $13.89 | $13.27 |
| Revenue Next Year | N/A | $17.62 |
| P/E Ratio | $11.72 | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $3.50 | $3.86 |
| 52 Week High | $6.44 | $10.62 |
| Indicator | GTN | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 38.20 | 60.11 |
| Support Level | $3.85 | $6.44 |
| Resistance Level | $5.10 | $6.66 |
| Average True Range (ATR) | 0.20 | 0.28 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 41.32 | 58.28 |
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.